Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines
Hepatitis C virus (HCV) is hepatotropic and only infects humans and chimpanzees. Consequently, an immunocompetent small animal model is lacking. The restricted tropism of HCV likely reflects specific host factor requirements. We investigated if dominant restriction factors expressed in non-liver or...
Gespeichert in:
Veröffentlicht in: | PLoS pathogens 2011-04, Vol.7 (4), p.e1002029-e1002029 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e1002029 |
---|---|
container_issue | 4 |
container_start_page | e1002029 |
container_title | PLoS pathogens |
container_volume | 7 |
creator | Frentzen, Anne Hüging, Kathrin Bitzegeio, Julia Friesland, Martina Haid, Sibylle Gentzsch, Juliane Hoffmann, Markus Lindemann, Dirk Zimmer, Gert Zielecki, Florian Weber, Friedemann Steinmann, Eike Pietschmann, Thomas |
description | Hepatitis C virus (HCV) is hepatotropic and only infects humans and chimpanzees. Consequently, an immunocompetent small animal model is lacking. The restricted tropism of HCV likely reflects specific host factor requirements. We investigated if dominant restriction factors expressed in non-liver or non-human cell lines inhibit HCV propagation thus rendering these cells non-permissive. To this end we explored if HCV completes its replication cycle in heterokaryons between human liver cell lines and non-permissive cell lines from human non-liver or mouse liver origin. Despite functional viral pattern recognition pathways and responsiveness to interferon, virus production was observed in all fused cells and was only ablated when cells were treated with exogenous interferon. These results exclude that constitutive or virus-induced expression of dominant restriction factors prevents propagation of HCV in these cell types, which has important implications for HCV tissue and species tropism. In turn, these data strongly advocate transgenic approaches of crucial human HCV cofactors to establish an immunocompetent small animal model. |
doi_str_mv | 10.1371/journal.ppat.1002029 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1289132434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A256280902</galeid><doaj_id>oai_doaj_org_article_03bb75b6def04b5299f335b771c7e8d4</doaj_id><sourcerecordid>A256280902</sourcerecordid><originalsourceid>FETCH-LOGICAL-c660t-f723bec846ea918a900e5fe8473c6cd01d2608bd0cea8230a472af0b2b6022613</originalsourceid><addsrcrecordid>eNqVk8tu1DAUhiMEoqXwBggssUAsZvAlcZwNUjXiMlIFEpe15dgnUw-JndrJqH0KXhlnJq06qBuUhW_f_9vnV06WvSR4SVhJ3m_9GJxql32vhiXBmGJaPcpOSVGwRcnK_PG9-Un2LMYtxjlhhD_NTmg6oYyy0-zPynd9C4P1DvkGXUJys4ONaIV2NowRBehbq9Ue0De6BWRdwgYI_rcKN95FBNe6HQ1EZHxnnXJDEsUhWD2J4p4fO-WQ827R2h0EpJxBnR8joMNaQ9umqYP4PHvSqDbCi3k8y359-vhz9WVx8e3zenV-sdCc42HRlJTVoEXOQVVEqApjKBoQeck01wYTQzkWtcEalKAMq7ykqsE1rTmmlBN2lr0--Patj3LOMkpCRUUYzVmeiPWBMF5tZR9sl8qVXlm53_BhI1UYbEpEYlbXZVFzAw3O64JWVcNYUZcl0SUIM3l9mG8b6w6MBjcE1R6ZHp84eyk3ficZFjmpqmTwdjYI_mpM6crOxik15SDlKAUvuKg4mcg3_5APFzdTG5Xeb13j07V68pTntOBU4ArTRC0foNJnoLPaO2hs2j8SvDsSJGaA62Gjxhjl-sf3_2C_HrP5gdXBxxiguYuOYDl1w22RcuoGOXdDkr26H_ud6Pb3Z38BL_wIPA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1289132434</pqid></control><display><type>article</type><title>Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Frentzen, Anne ; Hüging, Kathrin ; Bitzegeio, Julia ; Friesland, Martina ; Haid, Sibylle ; Gentzsch, Juliane ; Hoffmann, Markus ; Lindemann, Dirk ; Zimmer, Gert ; Zielecki, Florian ; Weber, Friedemann ; Steinmann, Eike ; Pietschmann, Thomas</creator><contributor>Rice, Charles M.</contributor><creatorcontrib>Frentzen, Anne ; Hüging, Kathrin ; Bitzegeio, Julia ; Friesland, Martina ; Haid, Sibylle ; Gentzsch, Juliane ; Hoffmann, Markus ; Lindemann, Dirk ; Zimmer, Gert ; Zielecki, Florian ; Weber, Friedemann ; Steinmann, Eike ; Pietschmann, Thomas ; Rice, Charles M.</creatorcontrib><description>Hepatitis C virus (HCV) is hepatotropic and only infects humans and chimpanzees. Consequently, an immunocompetent small animal model is lacking. The restricted tropism of HCV likely reflects specific host factor requirements. We investigated if dominant restriction factors expressed in non-liver or non-human cell lines inhibit HCV propagation thus rendering these cells non-permissive. To this end we explored if HCV completes its replication cycle in heterokaryons between human liver cell lines and non-permissive cell lines from human non-liver or mouse liver origin. Despite functional viral pattern recognition pathways and responsiveness to interferon, virus production was observed in all fused cells and was only ablated when cells were treated with exogenous interferon. These results exclude that constitutive or virus-induced expression of dominant restriction factors prevents propagation of HCV in these cell types, which has important implications for HCV tissue and species tropism. In turn, these data strongly advocate transgenic approaches of crucial human HCV cofactors to establish an immunocompetent small animal model.</description><identifier>ISSN: 1553-7374</identifier><identifier>ISSN: 1553-7366</identifier><identifier>EISSN: 1553-7374</identifier><identifier>DOI: 10.1371/journal.ppat.1002029</identifier><identifier>PMID: 21552323</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Animals ; Biology ; Cell Fusion ; Cell Line ; Gene expression ; Health aspects ; HEK293 Cells ; HeLa Cells ; Hepacivirus - physiology ; Hepatitis ; Hepatitis C virus ; Humans ; Interferon-alpha - pharmacology ; Liver ; Liver cells ; Medicine ; Mice ; Models, Animal ; Physiological aspects ; Proteins ; Rodents ; Transfection ; Viral infections ; Virus Replication - genetics</subject><ispartof>PLoS pathogens, 2011-04, Vol.7 (4), p.e1002029-e1002029</ispartof><rights>COPYRIGHT 2011 Public Library of Science</rights><rights>2011 Frentzen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Frentzen A, Hüging K, Bitzegeio J, Friesland M, Haid S, et al. (2011) Completion of Hepatitis C Virus Replication Cycle in Heterokaryons Excludes Dominant Restrictions in Human Non-liver and Mouse Liver Cell Lines. PLoS Pathog 7(4): e1002029. doi:10.1371/journal.ppat.1002029</rights><rights>Frentzen et al. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c660t-f723bec846ea918a900e5fe8473c6cd01d2608bd0cea8230a472af0b2b6022613</citedby><cites>FETCH-LOGICAL-c660t-f723bec846ea918a900e5fe8473c6cd01d2608bd0cea8230a472af0b2b6022613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084199/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084199/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21552323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Rice, Charles M.</contributor><creatorcontrib>Frentzen, Anne</creatorcontrib><creatorcontrib>Hüging, Kathrin</creatorcontrib><creatorcontrib>Bitzegeio, Julia</creatorcontrib><creatorcontrib>Friesland, Martina</creatorcontrib><creatorcontrib>Haid, Sibylle</creatorcontrib><creatorcontrib>Gentzsch, Juliane</creatorcontrib><creatorcontrib>Hoffmann, Markus</creatorcontrib><creatorcontrib>Lindemann, Dirk</creatorcontrib><creatorcontrib>Zimmer, Gert</creatorcontrib><creatorcontrib>Zielecki, Florian</creatorcontrib><creatorcontrib>Weber, Friedemann</creatorcontrib><creatorcontrib>Steinmann, Eike</creatorcontrib><creatorcontrib>Pietschmann, Thomas</creatorcontrib><title>Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines</title><title>PLoS pathogens</title><addtitle>PLoS Pathog</addtitle><description>Hepatitis C virus (HCV) is hepatotropic and only infects humans and chimpanzees. Consequently, an immunocompetent small animal model is lacking. The restricted tropism of HCV likely reflects specific host factor requirements. We investigated if dominant restriction factors expressed in non-liver or non-human cell lines inhibit HCV propagation thus rendering these cells non-permissive. To this end we explored if HCV completes its replication cycle in heterokaryons between human liver cell lines and non-permissive cell lines from human non-liver or mouse liver origin. Despite functional viral pattern recognition pathways and responsiveness to interferon, virus production was observed in all fused cells and was only ablated when cells were treated with exogenous interferon. These results exclude that constitutive or virus-induced expression of dominant restriction factors prevents propagation of HCV in these cell types, which has important implications for HCV tissue and species tropism. In turn, these data strongly advocate transgenic approaches of crucial human HCV cofactors to establish an immunocompetent small animal model.</description><subject>Animals</subject><subject>Biology</subject><subject>Cell Fusion</subject><subject>Cell Line</subject><subject>Gene expression</subject><subject>Health aspects</subject><subject>HEK293 Cells</subject><subject>HeLa Cells</subject><subject>Hepacivirus - physiology</subject><subject>Hepatitis</subject><subject>Hepatitis C virus</subject><subject>Humans</subject><subject>Interferon-alpha - pharmacology</subject><subject>Liver</subject><subject>Liver cells</subject><subject>Medicine</subject><subject>Mice</subject><subject>Models, Animal</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>Rodents</subject><subject>Transfection</subject><subject>Viral infections</subject><subject>Virus Replication - genetics</subject><issn>1553-7374</issn><issn>1553-7366</issn><issn>1553-7374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqVk8tu1DAUhiMEoqXwBggssUAsZvAlcZwNUjXiMlIFEpe15dgnUw-JndrJqH0KXhlnJq06qBuUhW_f_9vnV06WvSR4SVhJ3m_9GJxql32vhiXBmGJaPcpOSVGwRcnK_PG9-Un2LMYtxjlhhD_NTmg6oYyy0-zPynd9C4P1DvkGXUJys4ONaIV2NowRBehbq9Ue0De6BWRdwgYI_rcKN95FBNe6HQ1EZHxnnXJDEsUhWD2J4p4fO-WQ827R2h0EpJxBnR8joMNaQ9umqYP4PHvSqDbCi3k8y359-vhz9WVx8e3zenV-sdCc42HRlJTVoEXOQVVEqApjKBoQeck01wYTQzkWtcEalKAMq7ykqsE1rTmmlBN2lr0--Patj3LOMkpCRUUYzVmeiPWBMF5tZR9sl8qVXlm53_BhI1UYbEpEYlbXZVFzAw3O64JWVcNYUZcl0SUIM3l9mG8b6w6MBjcE1R6ZHp84eyk3ficZFjmpqmTwdjYI_mpM6crOxik15SDlKAUvuKg4mcg3_5APFzdTG5Xeb13j07V68pTntOBU4ArTRC0foNJnoLPaO2hs2j8SvDsSJGaA62Gjxhjl-sf3_2C_HrP5gdXBxxiguYuOYDl1w22RcuoGOXdDkr26H_ud6Pb3Z38BL_wIPA</recordid><startdate>20110401</startdate><enddate>20110401</enddate><creator>Frentzen, Anne</creator><creator>Hüging, Kathrin</creator><creator>Bitzegeio, Julia</creator><creator>Friesland, Martina</creator><creator>Haid, Sibylle</creator><creator>Gentzsch, Juliane</creator><creator>Hoffmann, Markus</creator><creator>Lindemann, Dirk</creator><creator>Zimmer, Gert</creator><creator>Zielecki, Florian</creator><creator>Weber, Friedemann</creator><creator>Steinmann, Eike</creator><creator>Pietschmann, Thomas</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110401</creationdate><title>Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines</title><author>Frentzen, Anne ; Hüging, Kathrin ; Bitzegeio, Julia ; Friesland, Martina ; Haid, Sibylle ; Gentzsch, Juliane ; Hoffmann, Markus ; Lindemann, Dirk ; Zimmer, Gert ; Zielecki, Florian ; Weber, Friedemann ; Steinmann, Eike ; Pietschmann, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c660t-f723bec846ea918a900e5fe8473c6cd01d2608bd0cea8230a472af0b2b6022613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Biology</topic><topic>Cell Fusion</topic><topic>Cell Line</topic><topic>Gene expression</topic><topic>Health aspects</topic><topic>HEK293 Cells</topic><topic>HeLa Cells</topic><topic>Hepacivirus - physiology</topic><topic>Hepatitis</topic><topic>Hepatitis C virus</topic><topic>Humans</topic><topic>Interferon-alpha - pharmacology</topic><topic>Liver</topic><topic>Liver cells</topic><topic>Medicine</topic><topic>Mice</topic><topic>Models, Animal</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>Rodents</topic><topic>Transfection</topic><topic>Viral infections</topic><topic>Virus Replication - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frentzen, Anne</creatorcontrib><creatorcontrib>Hüging, Kathrin</creatorcontrib><creatorcontrib>Bitzegeio, Julia</creatorcontrib><creatorcontrib>Friesland, Martina</creatorcontrib><creatorcontrib>Haid, Sibylle</creatorcontrib><creatorcontrib>Gentzsch, Juliane</creatorcontrib><creatorcontrib>Hoffmann, Markus</creatorcontrib><creatorcontrib>Lindemann, Dirk</creatorcontrib><creatorcontrib>Zimmer, Gert</creatorcontrib><creatorcontrib>Zielecki, Florian</creatorcontrib><creatorcontrib>Weber, Friedemann</creatorcontrib><creatorcontrib>Steinmann, Eike</creatorcontrib><creatorcontrib>Pietschmann, Thomas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS pathogens</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frentzen, Anne</au><au>Hüging, Kathrin</au><au>Bitzegeio, Julia</au><au>Friesland, Martina</au><au>Haid, Sibylle</au><au>Gentzsch, Juliane</au><au>Hoffmann, Markus</au><au>Lindemann, Dirk</au><au>Zimmer, Gert</au><au>Zielecki, Florian</au><au>Weber, Friedemann</au><au>Steinmann, Eike</au><au>Pietschmann, Thomas</au><au>Rice, Charles M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines</atitle><jtitle>PLoS pathogens</jtitle><addtitle>PLoS Pathog</addtitle><date>2011-04-01</date><risdate>2011</risdate><volume>7</volume><issue>4</issue><spage>e1002029</spage><epage>e1002029</epage><pages>e1002029-e1002029</pages><issn>1553-7374</issn><issn>1553-7366</issn><eissn>1553-7374</eissn><abstract>Hepatitis C virus (HCV) is hepatotropic and only infects humans and chimpanzees. Consequently, an immunocompetent small animal model is lacking. The restricted tropism of HCV likely reflects specific host factor requirements. We investigated if dominant restriction factors expressed in non-liver or non-human cell lines inhibit HCV propagation thus rendering these cells non-permissive. To this end we explored if HCV completes its replication cycle in heterokaryons between human liver cell lines and non-permissive cell lines from human non-liver or mouse liver origin. Despite functional viral pattern recognition pathways and responsiveness to interferon, virus production was observed in all fused cells and was only ablated when cells were treated with exogenous interferon. These results exclude that constitutive or virus-induced expression of dominant restriction factors prevents propagation of HCV in these cell types, which has important implications for HCV tissue and species tropism. In turn, these data strongly advocate transgenic approaches of crucial human HCV cofactors to establish an immunocompetent small animal model.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>21552323</pmid><doi>10.1371/journal.ppat.1002029</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1553-7374 |
ispartof | PLoS pathogens, 2011-04, Vol.7 (4), p.e1002029-e1002029 |
issn | 1553-7374 1553-7366 1553-7374 |
language | eng |
recordid | cdi_plos_journals_1289132434 |
source | MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central Open Access; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Animals Biology Cell Fusion Cell Line Gene expression Health aspects HEK293 Cells HeLa Cells Hepacivirus - physiology Hepatitis Hepatitis C virus Humans Interferon-alpha - pharmacology Liver Liver cells Medicine Mice Models, Animal Physiological aspects Proteins Rodents Transfection Viral infections Virus Replication - genetics |
title | Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T01%3A33%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Completion%20of%20hepatitis%20C%20virus%20replication%20cycle%20in%20heterokaryons%20excludes%20dominant%20restrictions%20in%20human%20non-liver%20and%20mouse%20liver%20cell%20lines&rft.jtitle=PLoS%20pathogens&rft.au=Frentzen,%20Anne&rft.date=2011-04-01&rft.volume=7&rft.issue=4&rft.spage=e1002029&rft.epage=e1002029&rft.pages=e1002029-e1002029&rft.issn=1553-7374&rft.eissn=1553-7374&rft_id=info:doi/10.1371/journal.ppat.1002029&rft_dat=%3Cgale_plos_%3EA256280902%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1289132434&rft_id=info:pmid/21552323&rft_galeid=A256280902&rft_doaj_id=oai_doaj_org_article_03bb75b6def04b5299f335b771c7e8d4&rfr_iscdi=true |